West German Study Group

This study is comparing two different treatment strategies for patients with early-stage, HER2-positive breast cancer before they have surgery. It aims to see if a newer, targeted drug called trastuzumab-deruxtecan (T-DXd) works better and is easier to tolerate than the current s…

This large study is testing if adding a drug called abemaciclib to standard hormone therapy is better at preventing breast cancer from returning. It is for women with a high risk of their cancer coming back after initial treatment. The goal is to see if this combination helps pat…